Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

Novo Nordisk's weight loss injection cut obesity in young children, trial shows

In the STEP Young trial, BMI fell an estimated 17.4% with semaglutide and rose 2.2% with placebo at week 68 among children 6 to under 12

Novo Nordisk's weight loss injection cut obesity in young children, trial shows

We haven't written up this one. Quartz has the full story — the link below goes straight to it.

Read the original at qz.com →

Report a problem with this story

More in Health & Medicine

More from Monday 16 November →